Short chain fatty acids (butyric acid) and intestinal diseases

Intro: Short chain fatty acids Comprise up to 6 carbon atoms. One of these, butyric acid stands out because of its key part in pathologies with intestinal affectation. Butyric acid is the key energetic substrate of this colonocyte, it stimulates the absorption of water and sodium from the colon, also introduces trophic activity on the cells.

Aims: to Examine the clinical usage of formulations to the oral use of butyric acid.

Approaches: Overview of printed articles on oral supplementation with butyric acid in intestinal pathologies.

Effects: The books mainly Take Care of the use of oral butyric acid In pathologies involving inflammation and / or adjustments of intestinal motility. Highlighting the clinical potential in inflammatory bowel diseases and irritable bowel syndrome.

Conclusion: Using oral supplementation with butyric acid is a promising Approach in pathologies like inflammatory bowel diseases and irritable bowel syndrome. Bio-available butyric acid formulations with suitable organoleptic Attributes are being sophisticated.